During the past decade, Asian Institute of Gastroenterology conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 10 clinical trials were completed, i.e. on average, 23.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asian Institute of Gastroenterology" #1 sponsor was "Asian Institute of Gastroenterology, India" with 29 trials, followed by "Boston Scientific Corporation" with 11 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Johns Hopkins University" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asian Institute of Gastroenterology" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "American Society for Gastrointestinal Endoscopy" with 1 trials as a collaborator, "Apollo Gleneagles Hospitals, Kolkata" with 1 trials as a collaborator, "Asian Institute of Gastroenterology" with 1 trials as a collaborator and "Asian Institute of Gastroenterology, India" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Asian Institute of Gastroenterology" are "Chronic Pancreatitis" (6 trials), "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials), "Biliary Stricture" (3 trials) and "Chronic Pain" (2 trials). Many other conditions were trialed in "Asian Institute of Gastroenterology" in a lesser frequency.

Most popular intervention types in "Asian Institute of Gastroenterology" are "Device" (21 trials), "Drug" (19 trials), "Procedure" (10 trials), "Other" (6 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Bio-enhanced Curcumin Soft Gelatin Capsule" (2 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Asian Institute of Gastroenterology" are 55 trials for "All" genders.

Currently, there are NaN active trials in "Asian Institute of Gastroenterology". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Asian Institute of Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asian Institute of Gastroenterology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".